Drug Type Synthetic peptide |
Synonyms + [1] |
Target |
Mechanism enteropeptidase inhibitors(Enteropeptidase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | FR | - | |
Obesity | Preclinical | FR | - |